XClose

UCL Institute of Health Informatics

Home
Menu

New Cochrane Heart Group Systematic Review of Evidence

24 November 2016

A new systematic review has just been published on the benefits and harms of ablation (using either catheter or surgery) to heart rhythm drugs in people with persistent or long-standing persistent (non-paroxysmal) atrial fibrillation.

Evidence suggests that radiofrequency catheter ablation (RFCA) is effective in achieving freedom from atrial arrhythmias, reducing the need for cardioversion, and reducing cardiac-related hospitalisations compared to antiarrhythmic drugs while uncertainty remains as to its effect with significant bradycardia (or need for a pacemaker), periprocedural complications, and other safety outcomes. 

Read more here: https://t.co/JGX7jhnP3s

Nyong J, Amit G, Adler AJ, Owolabi OO, Perel P, Prieto-Merino D, Lambiase P, Casas JP, Morillo CA. Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation. Cochrane Database of Systematic Reviews 2016, Issue 11. Art. No.: CD012088. DOI: 10.1002/14651858.CD012088.pub2.